نتایج جستجو برای: hiv vaccine

تعداد نتایج: 309384  

Journal: :Science translational medicine 2011
Lawrence Corey Gary J Nabel Carl Dieffenbach Peter Gilbert Barton F Haynes Margaret Johnston James Kublin H Clifford Lane Giuseppe Pantaleo Louis J Picker Anthony S Fauci

Developing a vaccine against the human immunodeficiency virus (HIV) poses an exceptional challenge. There are no documented cases of immune-mediated clearance of HIV from an infected individual, and no known correlates of immune protection. Although nonhuman primate models of lentivirus infection have provided valuable data about HIV pathogenesis, such models do not predict HIV vaccine efficacy...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999
W J Moss F Cutts D E Griffin

Human immunodeficiency virus (HIV)-infected persons may be important, unrecognized transmitters of measles virus, thwarting eradication efforts. We reviewed the published English-language literature on measles and measles immunization in HIV-infected persons to investigate the clinical features of measles, the responses to measles immunization, and the safety of measles vaccine in HIV-infected ...

Journal: :Journal of family medicine and disease prevention 2023

Many people are infected with human immunodeficiency virus (HIV) every year. Due to the unique properties of this virus, no effective vaccine has been approved prevent virus. HIV is transmitted a healthy person in various ways, such as sex, using an syringe, etc. So far, ways have proposed spread however, number continues increase Various factors play role process disease transmission.

Journal: :The New England journal of medicine 2010
Neil French Stephen B Gordon Thandie Mwalukomo Sarah A White Gershom Mwafulirwa Herbert Longwe Martin Mwaiponya Eduard E Zijlstra Malcolm E Molyneux Charles F Gilks

BACKGROUND Streptococcus pneumoniae is a leading and serious coinfection in adults with human immunodeficiency virus (HIV) infection, particularly in Africa. Prevention of this disease by vaccination with the current 23-valent polysaccharide vaccine is suboptimal. Protein conjugate vaccines offer a further option for protection, but data on their clinical efficacy in adults are needed. METHOD...

Journal: :International reviews of immunology 2009
Antonella Caputo Riccardo Gavioli Stefania Bellino Olimpia Longo Antonella Tripiciano Vittorio Francavilla Cecilia Sgadari Giovanni Paniccia Fausto Titti Aurelio Cafaro Flavia Ferrantelli Paolo Monini Fabrizio Ensoli Barbara Ensoli

The HIV epidemic continues to represent one of the major problems worldwide, particularly in the Asia and Sub-Saharan regions of the world, with social and economical devastating effects. Although antiretroviral drugs have had a dramatically beneficial impact on HIV-infected individuals that have access to treatment, it has had a negligible impact on the global epidemic. Hence, the inexorable s...

Journal: :The New England journal of medicine 2013
Scott M Hammer Magdalena E Sobieszczyk Holly Janes Shelly T Karuna Mark J Mulligan Doug Grove Beryl A Koblin Susan P Buchbinder Michael C Keefer Georgia D Tomaras Nicole Frahm John Hural Chuka Anude Barney S Graham Mary E Enama Elizabeth Adams Edwin DeJesus Richard M Novak Ian Frank Carter Bentley Shelly Ramirez Rong Fu Richard A Koup John R Mascola Gary J Nabel David C Montefiori James Kublin M Juliana McElrath Lawrence Corey Peter B Gilbert

BACKGROUND A safe and effective vaccine for the prevention of human immunodeficiency virus type 1 (HIV-1) infection is a global priority. We tested the efficacy of a DNA prime-recombinant adenovirus type 5 boost (DNA/rAd5) vaccine regimen in persons at increased risk for HIV-1 infection in the United States. METHODS At 21 sites, we randomly assigned 2504 men or transgender women who have sex ...

2013
Batul Diwan Rupali Saxena Archana Tiwari

Acquired Immunodeficiency Syndrome (AIDS) is one of the most critically acclaimed endemic diseases, caused by two lentiviruses HIV-1 and 2. HIV-2 displays intimate serological and antigenic resemblance to Simian Immunodeficiency Virus (SIV) along with less pathogenicity, lower infectivity and appreciable cross reactivity with HIV-1 antigens. The present era is confronted with the challenge to f...

Journal: :PLoS ONE 2007
Sven Létourneau Eung-Jun Im Tumelo Mashishi Choechoe Brereton Anne Bridgeman Hongbing Yang Lucy Dorrell Tao Dong Bette Korber Andrew J. McMichael Tomáš Hanke

BACKGROUND One of the big roadblocks in development of HIV-1/AIDS vaccines is the enormous diversity of HIV-1, which could limit the value of any HIV-1 vaccine candidate currently under test. METHODOLOGY AND FINDINGS To address the HIV-1 variation, we designed a novel T cell immunogen, designated HIV(CONSV), by assembling the 14 most conserved regions of the HIV-1 proteome into one chimaeric ...

Journal: :Current HIV research 2004
Chitsanu Pancharoen Jintanat Ananworanich Usa Thisyakorn

Immunization is an important measure to protect HIV-infected children and adults against certain vaccine preventable diseases. However, the antibody response, which is associated with the level of CD4+ T cell count, is frequently impaired in this group of patients. Certain vaccines enhance virus replication and transiently increase HIV viral load. Theoretically, vaccination should be given befo...

Journal: :CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2005
Thomas M Lampinen Keith Chan Robert S Remis Maraki Fikre Merid Melanie Rusch Jean Vincelette Ken Logue Vladimir Popovic Michel Alary Martin T Schechter Robert S Hogg

BACKGROUND Phase I and phase II HIV-1 vaccine trials have revealed increases in risky sexual activity among study subjects during the trials, perhaps because the subjects believe that the vaccine being tested is efficacious; subjects may thus suffer harm from their participation. We evaluated the sexual behaviour of Canadian men who have sex with men (MSM) who participated in the phase III Vax0...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید